Untargeted and Targeted Metabolomics Reveal the Underlying Mechanism of Aspirin Eugenol Ester Ameliorating Rat Hyperlipidemia via Inhibiting FXR to Induce CYP7A1

MLA

Lu Xiao-Rong, et al. “Untargeted and Targeted Metabolomics Reveal the Underlying Mechanism of Aspirin Eugenol Ester Ameliorating Rat Hyperlipidemia via Inhibiting FXR to Induce CYP7A1.” Frontiers in Pharmacology, vol. 12, Nov. 2021. EBSCOhost, https://doi.org/10.3389/fphar.2021.733789/full.

APA

Lu Xiao-Rong, Ma Ning, Liu Xi-Wang, Li Shi-Hong, Qin Zhe, Bai Li-Xia, Yang Ya-Jun, & Li Jian-Yong. (2021). Untargeted and Targeted Metabolomics Reveal the Underlying Mechanism of Aspirin Eugenol Ester Ameliorating Rat Hyperlipidemia via Inhibiting FXR to Induce CYP7A1. Frontiers in Pharmacology, 12. https://doi.org/10.3389/fphar.2021.733789/full

Chicago

Lu Xiao-Rong, Ma Ning, Liu Xi-Wang, Li Shi-Hong, Qin Zhe, Bai Li-Xia, Yang Ya-Jun, and Li Jian-Yong. 2021. “Untargeted and Targeted Metabolomics Reveal the Underlying Mechanism of Aspirin Eugenol Ester Ameliorating Rat Hyperlipidemia via Inhibiting FXR to Induce CYP7A1.” Frontiers in Pharmacology 12 (November). doi:10.3389/fphar.2021.733789/full.